Chart, page-30

  1. 1,258 Posts.
    lightbulb Created with Sketch. 148
    you literally said: What the Eff does Australian GDP figures have to do with, or influence upon, an Australian biotech awaiting approval in the USA? which implies what: a fundamental or technical perspective? why did you need to caveat the "awaiting approval" line if it's just price history you are looking at?

    I will concede I overthought what you were trying to communicate and mostly reacted to the above statement and your smug dismissal (Also i have itchy on mute hence further confusion): all i was trying to communicate was that (off the back of yes largely US driven movements which I acknowledged before the market opened) that GDP figures could have driven the stocks further down or back up when they deviate from consensus expectations. There is a reason why its flagged red in economic calendars and why most before the bell articles were telling investors to look out for it: despite it being a lagging indicator.

    with respect to this being the chart thread: also fair, but I will put this to you rhetorically: did we come ever so closer to the 80 cent gap (lol) today because a) the US market was down last night? or b) because there was a gap in the Mesoblast in the price history?

    I will leave it to yourself and itchy to discuss the technicals going forward. Ta
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.64
Change
-0.030(1.80%)
Mkt cap ! $2.095B
Open High Low Value Volume
$1.67 $1.67 $1.62 $23.20M 14.15M

Buyers (Bids)

No. Vol. Price($)
3 217849 $1.64
 

Sellers (Offers)

Price($) Vol. No.
$1.65 69336 2
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.